from rob2_pipeline.methodology.types import (
    Citation,
    DomainMethodology,
    ResponseRule,
    RuleCard,
)

SUPP = "Sterne 2019 supplement"

DOMAIN5_METHODOLOGY = DomainMethodology(
    domain_id="D5",
    title="Bias in selection of the reported result",
    principles=[
        "Assess the specific numerical result for the outcome under review, not selective non-reporting of other outcomes at review level."
    ],
    rule_cards={
        "5.1": RuleCard(
            "5.1",
            "Were data analysed according to a pre-specified plan finalized before unblinded outcome data were available?",
            {
                "Y": ResponseRule(
                    "A sufficiently detailed pre-specified plan was finalized before unblinded data and followed."
                ),
                "PY": ResponseRule(
                    "Strong indication of pre-specification exists, with some detail missing or minor justified deviations."
                ),
                "PN": ResponseRule(
                    "A plan is mentioned but not detailed enough, or unexplained deviations raise concern."
                ),
                "N": ResponseRule(
                    "Clear post hoc decisions, endpoint switching, or result-based changes occurred."
                ),
                "NI": ResponseRule(
                    "No adequate information on pre-specified analysis intentions or timing."
                ),
            },
            [Citation(SUPP, "p.26")],
            notes=[
                "Answer Y or PY for 5.1 if a trial registration number is cited and the registration predates the primary analysis, or if the paper explicitly states that primary endpoints or the statistical analysis plan were prespecified or publicly available. Do not require every statistical detail, such as covariate lists, imputation methods, or sensitivity analyses, to be reprinted in the paper itself. A registration number combined with a prespecification claim is sufficient for Y. Answer PN only if there is specific evidence that the analysis plan changed after data unblinding, or if no registration exists and no prespecification is documented anywhere.",
                "If a ClinicalTrials.gov registry description is provided above and lists PRIMARY, SECONDARY, or TERTIARY objectives, treat these as evidence that objectives were described in the registry. Objectives alone are not the same as prespecified endpoint definitions or a finalized pre-unblinding statistical analysis plan; use them together with protocol, SAP, amendment, and results-reporting evidence when judging Q5.1.",
            ],
        ),
        "5.2": RuleCard(
            "5.2",
            "Was the result selected, on the basis of the results, from multiple eligible outcome measurements within the outcome domain?",
            {
                "Y": ResponseRule(
                    "Multiple eligible measurements existed, only a subset is reported without justification, and result-based selection is clear."
                ),
                "PY": ResponseRule(
                    "Multiple eligible measurements likely existed and reporting appears potentially selective."
                ),
                "PN": ResponseRule(
                    "Most intended measurements are reported or omissions are explained."
                ),
                "N": ResponseRule(
                    "All intended eligible measurements are reported, only one measurement was possible, or inconsistencies are unrelated to results."
                ),
                "NI": ResponseRule(
                    "Analysis intentions are unavailable or insufficient and multiple eligible measurements could have existed."
                ),
            },
            [Citation(SUPP, "p.26-27")],
            notes=[
                "Examples include different scales, definitions, or time points.",
                "A pre-specified composite endpoint is NOT multiple eligible outcome measurements merely because it combines several components into one measure. Answer Q5.2=N for composite endpoints unless there is evidence that specific components were selected post-hoc. Answer Q5.2=Y/PY only when the paper reports one specific scale, definition, component, or time point chosen from several separately pre-specified alternatives based on the observed results.",
                "Pre-specified co-primary endpoints are not multiple eligible outcome measurements relative to each other: each is pre-specified and expected to be reported. Reporting multiple pre-specified co-primary endpoints does not by itself constitute selective outcome selection for any one endpoint.",
            ],
        ),
        "5.3": RuleCard(
            "5.3",
            "Was the result selected, on the basis of the results, from multiple eligible analyses of the data?",
            {
                "Y": ResponseRule(
                    "Multiple eligible analyses existed, only a subset is reported without justification, and result-based selection is clear."
                ),
                "PY": ResponseRule(
                    "Multiple analyses likely existed and reporting appears potentially selective."
                ),
                "PN": ResponseRule(
                    "Intended analyses are mostly reported or omissions are explained."
                ),
                "N": ResponseRule(
                    "All intended analyses are reported, only one analysis was possible, or inconsistencies are unrelated to results."
                ),
                "NI": ResponseRule(
                    "Analysis intentions are unavailable or insufficient and multiple eligible analyses could have existed."
                ),
            },
            [Citation(SUPP, "p.27-28")],
            notes=[
                "A particular outcome measurement may be analysed in multiple ways. Examples include: unadjusted and adjusted models; final value vs change from baseline vs analysis of covariance; transformations of variables; different definitions of composite outcomes; conversion of continuously scaled outcome to categorical data with different cut-points; different sets of covariates for adjustment; and different strategies for dealing with missing data."
            ],
        ),
    },
)
